To include your compound in the COVID-19 Resource Center, submit it here.

NaPro selling paclitaxel business

NPRO signed an agreement to sell its generic injectable paclitaxel business to Faulding Pharmaceutical,

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE